Synonym: Melanin Concentrating Hormone Receptor 1, MCH1R, SLC1, Melanin-Concentrating Hormone Receptor 1, GPR24, Somatostatin Receptor-Like Protein, G Protein-Coupled Receptor 24, MCH Receptor 1, MCH-1R, SLC-1, G-Protein Coupled Receptor 24, MCH-R1, MCHR-1, MCHR

About Human Melanin-Concentrating Hormone Receptor 1 (MCHR1) Stable Cell Line

Melanin-Concentrating Hormone Receptor 1 (MCHR1) is a Class A G protein-coupled receptor (GPCR) that serves as the primary receptor for melanin-concentrating hormone (MCH), a neuropeptide involved in the regulation of energy balance, feeding behavior, mood, sleep, and neuroendocrine function. MCHR1 is predominantly expressed in the central nervous system, particularly in regions of the hypothalamus, limbic system, and other brain areas associated with appetite regulation and emotional processing. Upon activation by MCH, MCHR1 primarily couples to Gq and Gi/o proteins, leading to intracellular calcium mobilization, modulation of cAMP signaling, and activation of downstream pathways including MAPK and ERK signaling cascades.

MCHR1 plays a critical role in controlling food intake, body weight regulation, energy homeostasis, and reward-associated behaviors. Numerous studies have demonstrated that activation of the MCH-MCHR1 signaling pathway promotes feeding behavior and positive energy balance, making MCHR1 an attractive therapeutic target for obesity and metabolic disorders. In addition, MCHR1 has been implicated in the regulation of anxiety, depression, sleep-wake cycles, addiction, and stress responses. Consequently, the receptor has become an important target for neuroscience research and pharmaceutical drug discovery programs.

eEnzyme's Human MCHR1 Stable Cell Line provides a reliable and reproducible cellular platform for investigating MCHR1-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of agonists, antagonists, inverse agonists, and allosteric modulators through calcium mobilization assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, compound profiling, lead optimization, and high-throughput screening applications targeting obesity, metabolic disease, and neurological disorders.

Applications of the MCHR1 Stable Cell Line

• MCHR1 receptor pharmacology studies
• Melanin-concentrating hormone (MCH) signaling research
• Agonist and antagonist screening
• Obesity and metabolic disease drug discovery
• Appetite regulation and energy balance studies
• Calcium mobilization and GPCR signaling assays
• Neuropsychiatric and sleep disorder research
• High-throughput screening applications

Biological Significance of MCHR1

MCHR1 is a key regulator of energy homeostasis and neurobehavioral function. Activation of MCHR1 by melanin-concentrating hormone stimulates feeding behavior, promotes energy storage, and influences metabolic regulation through complex neuronal circuits within the hypothalamus and limbic system. Beyond metabolism, MCHR1 signaling contributes to emotional regulation, stress responses, reward pathways, sleep architecture, and cognitive processes. Dysregulation of the MCH-MCHR1 pathway has been associated with obesity, depression, anxiety disorders, addiction, and sleep disturbances. Because of its broad physiological roles and therapeutic potential, MCHR1 remains an important target for GPCR research, neuroscience investigations, and the development of novel therapeutics for metabolic and neuropsychiatric disorders. The MCHR1 Stable Cell Line provides a valuable tool for studying receptor pharmacology and advancing MCHR1-targeted drug discovery programs.